Sensitive detection of copper ions (Cu²⁺) in biological samples is extremely important since an abnormal level of Cu²⁺ is linked with many diseases. Herein, we demonstrated a novel turn-on colorimetric sensor for selective detection of Cu²⁺ both in buffered solution and serum samples based on porous bimetallic transition metal oxide nanocages (ZnO-Co₃O₄ NCs) as peroxidase mimics. The ZnO-Co₃O₄ NCs were prepared by using ZnCo-zeolitic-imidazolate-framework (ZnCo-ZIF) as precursors via direct calcination. With the high peroxidase-like activity, the obtained ZnO-Co₃O₄ NCs can catalyze the oxidation of tetramethylbenzidine (TMB) in the presence of H₂O₂ to form a blue colored product. The inhibition effect of cysteine (Cys) on the catalytic activity of ZnO-Co₃O₄ NCs and its strong binding ability toward Cu²⁺ enabled the ZnO-Co₃O₄ NCs/Cys system to be utilized for sensitive detection of Cu²⁺, in which the catalytic activity of ZnO-Co₃O₄ NCs/Cys can be recovered by the introduction of Cu²⁺ with an obvious color change of the solution. The linear range for Cu²⁺ determination was 2 to 100 nM with a detection limit of 1.08 nM. More importantly, this colorimetric sensor has been successfully applied to detect Cu²⁺ in serum without pretreatment. Our findings are expected to expand the scope of application of nanozyme and shed light on early disease diagnosis.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: